US-based biopharmaceutical company Kadmon Holdings (Kadmon) has announced a public offering of common stock shares to raise up to $40m in total.

The company plans to use the funds towards clinical development of its product candidates and general corporate purposes.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Antares Pharma has announced plans to raise $30m through a public offering of its common stock shares.

"Antares Pharma has announced plans to raise $30m through a public offering of its common stock shares."

The US-based specialist pharmaceutical company plans to use the funds for general corporate purposes.

SK Capital has announced plans to acquire Perrigo API, the active pharmaceutical ingredients (API) business of Perrigo Company, for $110m.

SK Capital is a private investment firm based in the US, while Perrigo is an Irish healthcare company. The transaction will complement the existing businesses of SK Capital.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Pharmaceutical Technology Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving pharmaceutical advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now